Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
The Pavlovian Journal of Biological Science
|
January 1, 1979
Conditioning and the classification of the chronic schizophrenic patient
T A Ban, J V Ananth, H E Lehmann
Canadian Medical Association Journal
|
November 21, 1970
Tolbutamide jundice associated with multiple drug therapy
J V Ananth, T A Ban, H E Lehmann
Canadian Psychiatric Association Journal
|
January 1, 1972
Test-retest performance in chronic schizophrenia on the Verdun Conditioning Program
J V Ananth, T A Ban, H E Lehmann
Canadian Psychiatric Association Journal
|
February 1, 1970
Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics
J V Ananth, T A Ban, H E Lehmann, et al.
Current Therapeutic Research, Clinical and Experimental
|
April 1, 1970
CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients
C Villeneuve, J V Ananth, T A Ban, et al.
Canadian Psychiatric Association Journal
|
April 1, 1972
Propericiazine in psychiatric emergencies. A controlled comparative study
J V Ananth, M Salib, T A Ban, et al.
Current Therapeutic Research, Clinical and Experimental
|
September 1, 1970
Fluspirilene in the treatment of chronic schizophrenic patients
G Chouinard, T A Ban, H E Lehmann, et al.
Current Therapeutic Research, Clinical and Experimental
|
April 1, 1973
Diazepam in the treatment of insomnia in psychiatric patients
J V Ananth, L A Bronheim, A Klingner, et al.
The Journal of Clinical Pharmacology and New Drugs
|
July 1, 1971
Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function
J Leckman, J V Ananth, T A Ban, et al.
Laval Medical
|
September 1, 1970
Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients
J V Ananth, S Horodesky, H E Lehmann, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
The Pavlovian Journal of Biological Science
|
January 1, 1979
Conditioning and the classification of the chronic schizophrenic patient
T A Ban, J V Ananth, H E Lehmann
Canadian Medical Association Journal
|
November 21, 1970
Tolbutamide jundice associated with multiple drug therapy
J V Ananth, T A Ban, H E Lehmann
Canadian Psychiatric Association Journal
|
January 1, 1972
Test-retest performance in chronic schizophrenia on the Verdun Conditioning Program
J V Ananth, T A Ban, H E Lehmann
Canadian Psychiatric Association Journal
|
February 1, 1970
Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics
J V Ananth, T A Ban, H E Lehmann, et al.
Current Therapeutic Research, Clinical and Experimental
|
April 1, 1970
CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients
C Villeneuve, J V Ananth, T A Ban, et al.
Canadian Psychiatric Association Journal
|
April 1, 1972
Propericiazine in psychiatric emergencies. A controlled comparative study
J V Ananth, M Salib, T A Ban, et al.
Current Therapeutic Research, Clinical and Experimental
|
September 1, 1970
Fluspirilene in the treatment of chronic schizophrenic patients
G Chouinard, T A Ban, H E Lehmann, et al.
Current Therapeutic Research, Clinical and Experimental
|
April 1, 1973
Diazepam in the treatment of insomnia in psychiatric patients
J V Ananth, L A Bronheim, A Klingner, et al.
The Journal of Clinical Pharmacology and New Drugs
|
July 1, 1971
Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function
J Leckman, J V Ananth, T A Ban, et al.
Laval Medical
|
September 1, 1970
Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients
J V Ananth, S Horodesky, H E Lehmann, et al.
Page
of 5